本文へ移動
cccskills
無料GitHub で公開

esa-pa-skip-confirmatory-testing

This skill determines whether confirmatory testing can be omitted after a positive aldosterone-to-renin ratio (ARR) in patients with suspected primary aldosteronism. It is applied when a patient exhibits spontaneous hypokalemia, undetectable renin, and a plasma aldosterone concentration ≥20 ng/dL (550 pmol/L).

インストール方法を見る

含まれるファイル(1)

  • SKILL.md2.6 KB

SKILL.md(原文)

インストールする前に、エージェントに与えられる指示の中身を確認できます。

Determine When to Skip Confirmatory Testing for PA

STEP 1 — Gather Information

Confirm a positive ARR; assess serum potassium for spontaneous hypokalemia (K⁺ <3.5 mmol/L without diuretic cause); measure plasma renin activity (or direct renin concentration) to verify undetectable levels (< assay detection limit); obtain plasma aldosterone concentration (PAC).

STEP 2 — Rule In / Rule Out

Is the patient spontaneously hypokalemic AND renin undetectable AND PAC ≥20 ng/dL (550 pmol/L)?

  • Yes → proceed to Step 3 (skip confirmatory testing).
  • No → proceed to Step 3 (perform confirmatory testing).

STEP 3 — Classify or Stratify

If criteria met: classify as high‑confidence PA (can move directly to subtype testing).
If criteria not met: classify as indeterminate PA (requires confirmatory testing to confirm/exclude diagnosis).

STEP 4 — Decide

  • For high‑confidence PA: skip confirmatory testing; advance to adrenal CT for subtype evaluation.
  • For indeterminate PA: perform a confirmatory test (e.g., saline infusion test, fludrocortisone suppression test, captopril challenge test, or furosemide upright test) per guideline recommendations.

Clinical Guardrails / Mimics / Pitfalls

Do not mislabel diuretic‑induced hypokalemia as spontaneous; ensure renin assay sensitivity is adequate to detect low levels. Avoid skipping confirmatory testing in patients with severe uncontrolled hypertension, renal insufficiency, or recent mineralocorticoid receptor antagonist use without adequate washout, as these increase false‑positive risk. Remember that skipping testing raises the chance of misdiagnosing bilateral adrenal hyperplasia as unilateral disease.

Concrete Clinical Example

A 48‑year‑old hypertensive patient presents with spontaneous hypokalemia (K⁺ 3.0 mmol/L), undetectable renin (<0.1 ng/mL/h), PAC 24 ng/dL, and a positive ARR. Criteria are met, so confirmatory testing is skipped; the patient proceeds directly to adrenal CT, which shows a 1.2 cm left adrenal nodule, leading to laparoscopic adrenalectomy.

Source: The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2016, DOI:10.1210/jc.2015-4061

レビュー

まだレビューはありません。使ってみた感想をお寄せください。

同じリポジトリのスキル

概要と使いどころ

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

dromlakhani のスキルをすべて見る

このスキルの問題を報告する